Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00003490. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy of Isatuximab-based Regimens in Relapsed/Refractory Multiple Myeloma With 1q21+
ClinicalTrials.gov study NCT06874530. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Study to Evaluate LVIVO-TaVec200 for the Treatment of Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT07294625. IPD Sharing: NO. Countries: 1. Publications: 0.
Viral Therapy in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01533194. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Non Interventional Study to Investigate the Safety and Effectiveness in Patients With Relapsed and Refractory Multiple Myeloma Treated With Elranatamab Under the Actual Use.
ClinicalTrials.gov study NCT06479954. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase I Study of Bendamustine and Melphalan Conditioning and Autologous Stem Cell Transplantation for Treatment of Multiple Myeloma and Relapsed/Refractory B-cell Lymphoma in Elderly Patients
ClinicalTrials.gov study NCT03352765. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Isatuximab, Carfilzomib, and Pomalidomide for the Treatment of Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04850599. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Biomarkers Related to Thrombosis in Patients With Newly Diagnosed Multiple Myeloma Receiving Chemotherapy
ClinicalTrials.gov study NCT01132833. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase Ib/II Clinical Study on the Application of Linperlisib Combined with the VRD Regimen in Newly Diagnosed Patients with Multiple Myeloma
ClinicalTrials.gov study NCT06799676. IPD Sharing: NO. Countries: 1. Publications: 0.
Immune Profiling in Multiple Myeloma
ClinicalTrials.gov study NCT04135079. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Selinexor Maintenance Post CAR-T Cell Therapy for Multiple Myeloma
ClinicalTrials.gov study NCT07200102. IPD Sharing: YES. Countries: 1. Publications: 0.
Treatment of Relapsed/Refractory Multiple Myeloma (rrMM) With Pomalidomide in Clinical Practice
ClinicalTrials.gov study NCT02555839. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prospective Research Assessment in Multiple Myeloma: An Observational Evaluation (PREAMBLE)
ClinicalTrials.gov study NCT01838512. IPD Sharing: Not stated. Countries: 6. Publications: 0.
GR1803 Injection in Patients With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06566547. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy Study of CYT997 in Multiple Myeloma
ClinicalTrials.gov study NCT00664378. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Comparation of Chidamide Plus VRD (Bortezomib, Lenalidomide, Dexamethasone) With VRD Regimen for Primary High-Risk Multiple Myeloma Patients
ClinicalTrials.gov study NCT04025450. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Assess for Measurable Residual Disease (MRD) in Multiple Myeloma Patients
ClinicalTrials.gov study NCT04108624. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I Study of MIK665, a Mcl-1 Inhibitor, in Patients With Refractory or Relapsed Lymphoma or Multiple Myeloma
ClinicalTrials.gov study NCT02992483. IPD Sharing: NO. Countries: 7. Publications: 0.
A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma
ClinicalTrials.gov study NCT05827016. IPD Sharing: YES. Countries: 35. Publications: 0.
Vorinostat in Combination With Bortezomib, Doxorubicin and Dexamethasone (VBDD) in Patients With Refractory or Relapsed Multiple Myeloma (MM)
ClinicalTrials.gov study NCT01394354. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.